Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
01/2009
01/28/2009CN100455565C Sulfonamide anions as catalysts for nco oligomerization
01/27/2009US7482487 Phenylaminoethanol derivatives as β2 receptor agonists
01/27/2009US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma
01/27/2009CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
01/22/2009WO2009012205A1 Inhibitors of beta amyloid production
01/22/2009WO2009012203A1 Processes and intermediates for the preparation of heterocyclic sulfonamide compounds
01/22/2009US20090023903 Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides
01/22/2009US20090023791 PH-dependent NMDA receptor antagonists
01/22/2009US20090023735 Sulphonamide Derivatives
01/22/2009US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections
01/22/2009US20090022706 Substituted cyclohexenes
01/22/2009CA2693959A1 Inhibitors of beta amyloid production
01/21/2009EP2017261A1 Amine derivative having npy y5 receptor antagonist activity
01/21/2009EP1599490B1 Process for the preparation of anticonvulsant derivatives of topiramate
01/21/2009CN101351443A Method for producing sulfonamides
01/21/2009CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases
01/20/2009CA2502856C Intermediates for retroviral protease inhibiting compounds
01/20/2009CA2364944C C16 unsaturated fp-selective prostaglandins analogs
01/15/2009US20090018058 Vitamin D Receptor Modulators
01/14/2009EP2014285A1 NPYY5 antagonists
01/14/2009EP1331221B1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
01/14/2009CN101343251A Thrombopoietin mimetics
01/14/2009CN101343250A Thrombopoietin mimetics
01/14/2009CN101343244A Synthesis of sulfonylamines compounds
01/14/2009CN101342169A Thrombopoietin mimetics
01/13/2009CA2337397C 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
01/08/2009WO2009006267A2 N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles
01/08/2009WO2009005024A1 Method for producing optically active amine
01/08/2009WO2008131047A3 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
01/08/2009US20090012307 Process for the Preparation of 4-(imidazol-1-yl)benzenesulfonamide Derivatives
01/08/2009US20090012074 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the Dopamine D3 receptor
01/07/2009EP2010482A1 Coupling compounds and hair dyeing compositions containing them
01/07/2009CN101341183A Polyarylene and method for producing the same
01/07/2009CN101341143A Inhibitors of CCR9 activity
01/07/2009CN101341121A Inhibitors of CCR9 activity
01/07/2009CN100448444C Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
01/06/2009US7473686 Thrombopoietin mimetics
01/06/2009CA2308315C N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
01/06/2009CA2169219C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
01/01/2009US20090005394 Endothelin receptor antagonists
01/01/2009US20090004525 Ion-Dissociative Functional Compound, Method for Production Thereof, Ionic Conductor, and Electrochemical Device
12/2008
12/31/2008WO2008129288A3 Disulfonamides useful in the treatment of inflammation
12/31/2008WO2008121877A3 Cftr inhibitor compounds and uses thereof
12/31/2008EP2007717A1 Novel sulfonamide compounds
12/31/2008EP2007716A1 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008CA2186364C Substituted azetidinone compounds useful as hypocholesterolemic agents
12/25/2008US20080319225 A protective group is introduced to N-[(1R)-2(4-methoxyphenyl)-1-methylethyl]-N-[(1R)-1-phenylethyl)]amine, resulting amide is chlorosulfonated and the resulting sulfochloride is converted to a sulfonamide, from which 5-(2-aminopropyl)-2 methoxybenzenesulfonamide is produced by hydogenation wtih Pd
12/25/2008US20080318996 6-Amino(Aza)Indane Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
12/25/2008US20080318255 Fluorescent Labeled Sphingosines
12/24/2008WO2008157272A2 Deuterium-enriched tamsulosin
12/24/2008WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
12/24/2008WO2008124524A3 Aryl sulfonamide compounds as modulators of the cck2 receptor
12/24/2008EP2004649A2 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
12/24/2008EP2004596A2 Compositions useful as inhibitors of voltage-gated sodium channels
12/24/2008EP2004595A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
12/23/2008US7468360 Therapeutic amides and related compounds
12/23/2008CA2238427C Production method of aminobenzene compound
12/18/2008WO2008154414A2 Water- and oil-repellency imparting ester oligomers comprising perfluoroalkyl moieties
12/18/2008WO2008154372A1 Mutual prodrugs and methods to treat cancer
12/18/2008WO2008152653A2 An improved process for the preparation of tamsulosin hydrochloride
12/18/2008WO2008152334A2 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/18/2008WO2008152333A2 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/18/2008WO2008130332B1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
12/18/2008WO2008113756A3 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008WO2008077070A3 Crystal structures of hiv-1 protease inhibitors bound to hiv-1 protease
12/18/2008US20080312469 Preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
12/18/2008US20080312462 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
12/18/2008US20080312329 Nonpeptide Inhibitors of Matrix Metalloproteinases
12/18/2008US20080312328 Deuterium-enriched tamsulosin
12/18/2008US20080312231 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases
12/18/2008US20080311113 Method for treating adamts-5-associated disease
12/18/2008CA2690265A1 Mutual prodrugs and methods to treat cancer
12/18/2008CA2688241A1 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/18/2008CA2688239A1 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/17/2008EP2001838A2 Selective hydroxamate based mmp inhibitors
12/17/2008EP1773763B1 Lysine based compounds
12/17/2008EP1444199B1 Racemic tamsulosin free base and methods of making the same
12/17/2008EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases
12/17/2008CN101326161A Novel compounds
12/16/2008US7465834 Bis(dimethylamino)propylthiomethylium bis(trifluoromethanesulfonyl)imide; bis(dimethylamino)ethoxymethylium bis(trifluoromethanesulfonyl)imide; stable liquid state even at low temperatures; good conductivity
12/16/2008US7465829 N-halo-4-carboxybenzene sulfonamides; soap, lotion, wipe, or swab; minimal side effects; bactericide, pesticide, fungicide, deodorizing; also bovine teat cleaners, drugs for cultured fish, soap biocides, stain removal agents, and paint fungicides
12/11/2008WO2008151211A1 Substituted benzoylamino-indan-2-carboxylic acids and related compounds
12/11/2008WO2008008374A3 Ccr2 inhibitors and methods of use thereof
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080305506 including 8-hydroxypyrene-1,3,6-trislfonic acid (HPTS) and its derivatives; for analyte detection, determining blood glucose concentration
12/11/2008CA2690001A1 Substituted benzoylamino-indan-2-carboxylic acids and related compounds
12/10/2008EP1999133A2 Process for preparation of hiv protease inhibitors
12/10/2008EP1999107A2 Amine derivatives
12/10/2008EP1998761A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/10/2008EP1391199B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
12/10/2008CN101318927A Method for producing substituted phenylsulfonyl urea
12/10/2008CN101318918A Process for synthesizing substituted benzene sulfonic acid amide compound
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/09/2008CA2249958C Binuclear iridium(i) phosphine complexes and their use as catalyst in the asymmetric hydroamination of olefins
12/09/2008CA2217855C Tetralines
12/04/2008WO2008147797A2 Ion channel modulators and methods of use
12/04/2008US20080300280 Cyanobenzene Compounds for Combating Animal Pests
12/04/2008US20080300271 Novel compounds and a novel process for their preparation
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 177